1,3-DIBROMO-2,2-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE
Compound with spectra: 1 NMR
![1,3-DIBROMO-2,2-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE](/api/compound/5F8WymQkvLo.png?ph=true&h=300&w=458 "1,3-DIBROMO-2,2-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE")
| SpectraBase Compound ID | 5F8WymQkvLo |
|---|---|
| InChI | InChI=1S/C45H62Br2N8O2/c1-7-52(8-2)43(56)48-31-19-35-33-13-11-15-37-41(33)29(17-39(35)50(5)23-31)21-54(37)27-45(25-46,26-47)28-55-22-30-18-40-36(34-14-12-16-38(55)42(30)34)20-32(24-51(40)6)49-44(57)53(9-3)10-4/h11-16,21-22,31-32,35-36,39-40H,7-10,17-20,23-28H2,1-6H3,(H,48,56)(H,49,57)/t31-,32-,35+,36+,39+,40+/m0/s1 |
| InChIKey | JAFTZCSIYIBOHL-OYLPTLDHSA-N |
| Mol Weight | 906.9 g/mol |
| Molecular Formula | C45H62Br2N8O2 |
| Exact Mass | 904.336249 g/mol |
| Enantiomer InChIKey | JAFTZCSIYIBOHL-YIFUAGOTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
#5C;BROMO-2,2-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-3-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL]-PROPANE
1,3-DIBROMO-2-BROMOMETHYL-2-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE
1,6-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL]-HEXANE
1-(6-BROMOHEXYL)-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1-(2-AMINOETHYL)-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1-ALLYL-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1-CARBOXYMETHYL-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1,3-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-BENZENE
1,4-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-BENZENE
DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL]-METHANE
| Title | Journal or Book | Year |
|---|---|---|
| Clustered ergot alkaloids modulate cell-mediated cytotoxicity | Bioorganic & Medicinal Chemistry | 2002 |